- Home
- AMPG vs STTK Comparison
AMPG vs STTK Comparison
Compare AMPG & STTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMPG
- STTK
- Stock Information
- Founded
- AMPG 2002
- STTK 2016
- Country
- AMPG United States
- STTK United States
- Employees
- AMPG N/A
- STTK N/A
- Industry
- AMPG Telecommunications Equipment
- STTK Biotechnology: Pharmaceutical Preparations
- Sector
- AMPG Telecommunications
- STTK Health Care
- Exchange
- AMPG Nasdaq
- STTK Nasdaq
- Market Cap
- AMPG 46.7M
- STTK 37.6M
- IPO Year
- AMPG N/A
- STTK 2020
- Fundamental
- Price
- AMPG $2.10
- STTK $0.97
- Analyst Decision
- AMPG Strong Buy
- STTK Hold
- Analyst Count
- AMPG 1
- STTK 4
- Target Price
- AMPG $5.00
- STTK $3.00
- AVG Volume (30 Days)
- AMPG 185.6K
- STTK 316.5K
- Earning Date
- AMPG 08-13-2025
- STTK 07-31-2025
- Dividend Yield
- AMPG N/A
- STTK N/A
- EPS Growth
- AMPG N/A
- STTK N/A
- EPS
- AMPG N/A
- STTK N/A
- Revenue
- AMPG $10,814,140.00
- STTK $4,606,000.00
- Revenue This Year
- AMPG $114.55
- STTK N/A
- Revenue Next Year
- AMPG $50.00
- STTK N/A
- P/E Ratio
- AMPG N/A
- STTK N/A
- Revenue Growth
- AMPG N/A
- STTK 69.65
- 52 Week Low
- AMPG $0.64
- STTK $0.69
- 52 Week High
- AMPG $6.43
- STTK $4.99
- Technical
- Relative Strength Index (RSI)
- AMPG 51.21
- STTK 47.54
- Support Level
- AMPG $1.89
- STTK $0.91
- Resistance Level
- AMPG $2.08
- STTK $1.14
- Average True Range (ATR)
- AMPG 0.12
- STTK 0.08
- MACD
- AMPG -0.02
- STTK -0.01
- Stochastic Oscillator
- AMPG 39.22
- STTK 28.35
About AMPG Amplitech Group Inc.
AmpliTech Group Inc designs, develops, engineers, and assembles micro-wave component-based amplifiers that meet individual customer specifications. The products of the company consist of RF amplifiers & related subsystems, operating at multiple frequencies from 50kHz to 44GHz, including Low Noise Amplifiers, Medium Power Amplifiers, cryogenic amplifiers, and custom assemblies. The company also offers non-recurring engineering services on a project-by-project basis, for a predetermined fixed contractual amount, or on a time-plus-material basis. It also operates as a manufacturer, & distributor of cryogenic microwave amplifiers, RF designs, & applications for Wireless Networks & the future of Wireless Communication.
About STTK Shattuck Labs Inc.
Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.